Suraksha Diagnostic (SURAKSHA) | Stock Overview & Key Data
Suraksha Diagnostic Performance Comparison
Stock Range
Today's Range
Low: ₹288.20
High: ₹305.00
on August 8, 2025
52 Week Range
Low: ₹231.00
High: ₹449.00
on March 4, 2025
on December 6, 2024
All-Time High: ₹449.00 on December 2, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR15.5B
EPS
5.98
P/E Ratio (TTM)
49.87
Forward P/E
31.90
P/B Ratio
7.35
PEG Ratio
1.58
Div. Yield
N/A
ROE
15.91%
Beta
N/A
Debt to Equity
42.28
Financial Highlights
Profitability
Gross Margin
86.41%
Operating Margin
18.33%
Profit Margin
12.43%
Returns and Earnings
Return on Assets (TTM)
10.25%
Return on Equity (TTM)
15.91%
EBITDA
INR876.1M
Net Income (TTM)
INR318.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR49.14
Quarterly Revenue Growth (YoY)
17.30%
Quarterly Earnings Growth (YoY)
13.30%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Suraksha Diagnostic SURAKSHA | 15.53B Small-cap | -0.88% | -6.86% | 4.30% | -9.92% | -21.53% | -28.52% | -28.52% | -28.52% |
| Syngene SYNGENE | 270.39B Large-cap | -6.83% | 3.58% | 7.29% | -11.01% | -25.48% | -22.04% | 10.74% | 31.92% |
| Dr. Lal PathLabs LALPATHLAB | 266.23B Large-cap | 0.41% | 10.77% | 14.95% | 15.06% | 4.50% | -0.66% | 30.89% | 71.26% |
| Vimta Labs VIMTALABS | 28.27B Small-cap | -7.74% | 36.51% | 30.65% | 19.29% | 28.46% | 152.85% | 229.84% | 1,038.58% |
| Krsnaa Diagnostics KRSNAA | 27.52B Small-cap | 1.92% | 8.86% | 20.12% | 0.74% | -6.84% | 21.99% | 84.06% | -8.46% |
| Qualitek Labs QLL | 3.02B Small-cap | -4.20% | -3.32% | 3.63% | 8.46% | -17.51% | 3.90% | 95.48% | 95.48% |
Ownership & Short Interest
Insider Ownership
61.76%
Institutional Ownership
22.65%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
23K
Average 90-Day Volume
43K
Suraksha Diagnostic Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Suraksha Diagnostic would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SURAKSHA's 52-week high and low?
- In the last 52 weeks, Suraksha Diagnostic reached a high of ₹449.00 (on December 6, 2024) and a low of ₹231.00 (on March 4, 2025).
- What is the market cap and P/E ratio for SURAKSHA?
- Curious about Suraksha Diagnostic's size and valuation? Its market capitalization stands at 15.53B. When it comes to valuation, the P/E ratio (trailing twelve months) is 49.87, and the forward P/E (looking ahead) is 31.90.
- Does SURAKSHA pay dividends? If so, what's the yield?
- As for dividends, Suraksha Diagnostic isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Suraksha Diagnostic's main competitors or similar companies to consider before investing?
When looking at Suraksha Diagnostic, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Syngene
SYNGENE270.39B Healthcare Diagnostics & Research -22.04% 10.74% Dr. Lal PathLabs
LALPATHLAB266.23B Healthcare Diagnostics & Research -0.66% 30.89% Vimta Labs
VIMTALABS28.27B Healthcare Diagnostics & Research 152.85% 229.84% Krsnaa Diagnostics
KRSNAA27.52B Healthcare Diagnostics & Research 21.99% 84.06% Qualitek Labs
QLL3.02B Healthcare Diagnostics & Research 3.90% 95.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Suraksha Diagnostic Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Suraksha Diagnostic's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.91%, the Debt to Equity ratio from the most recent quarter is 42.28, and its Gross Profit Margin stands at 86.41%.
- What is the recent revenue and earnings growth for SURAKSHA?
- Looking at Suraksha Diagnostic's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 17.30%, and quarterly earnings saw a YoY growth of 13.30%.
- How much of SURAKSHA stock is held by insiders and institutions?
- Wondering who owns Suraksha Diagnostic stock? Company insiders (like executives and directors) hold about 61.76% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 22.65%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.